Literature DB >> 11467996

Induction, distribution and modulation of upper airway allergic inflammation in mice.

I Hussain1, D Randolph, S L Brody, S K Song, A Hsu, A M Kahn, D D Chaplin, D L Hamilos.   

Abstract

BACKGROUND: To further elucidate mechanisms of human allergic rhinosinusitis, we studied the induction, distribution and modulation of allergen-induced upper airway inflammation in a BALB/c mouse model.
METHODS: Allergic inflammation induced with ovalbumin (OVA) by intraperitoneal (IP) injection in alum was compared to repeated intranasal instillation. The type and distribution of inflammatory cells was compared in the respiratory and olfactory epithelial compartments. Eosinophil distribution was assessed using Scarlet Red stain and a polyclonal antibody recognizing eosinophil major basic protein (MBP). The role of interleukin (IL)-5 in upper airway inflammation was tested by administration of polyclonal anti-IL-5 antibody during the sensitization protocol.
RESULTS: Unsensitized control mice receiving saline failed to develop upper airway eosinophil infiltration. IP OVA-sensitized mice developed marked upper airway mucosal eosinophil infiltration after aerosol OVA challenge, whereas repeated intranasal instillation of OVA produced qualitatively similar, but less intense eosinophil infiltration. Using either sensitization protocol, eosinophil infiltration was seen in areas of the lower portion of the nasal septum, the floor and the lower lateral walls of the mid-caudal region of the nasal cavity. Immunofluorescence staining for MBP confirmed this distribution of eosinophils but also demonstrated some eosinophils in the maxillary sinuses and in circumscribed regions of the ethmoturbinates. All areas of eosinophil infiltration were lined by respiratory epithelium. The selective infiltration of respiratory but not olfactory epithelium by eosinophils was unassociated with a measurable induction of epithelial ICAM-1 or eotaxin expression. OVA-induced upper airway eosinophil infiltration was found to be IL-5 dependent, since administration of a polyclonal anti-IL-5 antibody (TRFK-5) during OVA sensitization resulted in a marked modulation (80% decrease) in eosinophil infiltration in response to subsequent OVA challenge.
CONCLUSION: The mouse upper airway, specifically in areas containing respiratory epithelium, is a target for OVA-induced allergic inflammation. This selective infiltration of respiratory, but not olfactory, epithelium is, in part, dependent upon IL-5. This model is useful for further dissection of the inflammatory response with genetic manipulations and targeted immunological approaches.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11467996     DOI: 10.1046/j.1365-2222.2001.01129.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  11 in total

Review 1.  Technical advances in rhinologic basic science research.

Authors:  Murugappan Ramanathan; Justin H Turner; Andrew P Lane
Journal:  Otolaryngol Clin North Am       Date:  2009-10       Impact factor: 3.346

2.  Probing local innate immune responses after mucosal immunisation.

Authors:  Lindsay J Hall; Simon Clare; Gordon Dougan
Journal:  J Immune Based Ther Vaccines       Date:  2010-09-13

3.  Role of the type I tumor necrosis factor receptor in inflammation-associated olfactory dysfunction.

Authors:  Davi Sousa Garcia; Mengfei Chen; Amy K Smith; Paulo Roberto Lazarini; Andrew P Lane
Journal:  Int Forum Allergy Rhinol       Date:  2016-09-27       Impact factor: 3.858

4.  T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection.

Authors:  Karen Smith Korsholm; Rune V Petersen; Else Marie Agger; Peter Andersen
Journal:  Immunology       Date:  2009-07-14       Impact factor: 7.397

5.  Three-dimensional analysis of rodent paranasal sinus cavities from X-ray computed tomography (CT) scans.

Authors:  Jonathan E Phillips; Lunan Ji; Maria A Rivelli; Richard W Chapman; Michel R Corboz
Journal:  Can J Vet Res       Date:  2009-07       Impact factor: 1.310

6.  Systemic administration of olygodeoxynucleotides with CpG motifs at priming phase reduces local Th2 response and late allergic rhinitis in BALB/c mice.

Authors:  Toshiharu Hayashi; Keiko Hasegawa; Yuji Sasaki
Journal:  Inflammation       Date:  2007-09-12       Impact factor: 4.092

7.  The Role of IL-17 in a Lipopolysaccharide-Induced Rhinitis Model.

Authors:  Jun Sang Bae; Ji Hye Kim; Eun Hee Kim; Ji Hun Mo
Journal:  Allergy Asthma Immunol Res       Date:  2017-03       Impact factor: 5.764

8.  Mouse Model of IL-17-Dominant Rhinitis Using Polyinosinic-Polycytidylic Acid.

Authors:  Jun Sang Bae; Eun Hee Kim; Ji Hye Kim; Ji Hun Mo
Journal:  Allergy Asthma Immunol Res       Date:  2017-11       Impact factor: 5.764

9.  In vivo determination of mouse olfactory mucus cation concentrations in normal and inflammatory states.

Authors:  Senthil Selvaraj; Kevin Liu; Alan M Robinson; Victoria A Epstein; David B Conley; Robert C Kern; Claus-Peter Richter
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

10.  Enhanced Interferon-β Response Contributes to Eosinophilic Chronic Rhinosinusitis.

Authors:  Yong Ju Jang; Ji Youn Lim; Seoyeon Kim; Yoo La Lee; Mi-Na Kweon; Ji Heui Kim
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.